Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer.

Sung Eun OhMin-Gew ChoiJun Ho LeeTae Sung SohnJae Moon BaeJi Yeong An

Published in: PloS one (2023)

MJLN dissection should be considered for advanced RGC patients who underwent gastrojejunostomy after distal gastrectomy during their initial surgery according to the index value.

Keyphrases

minimally invasive
end stage renal disease
newly diagnosed
prognostic factors
rectal cancer
prostate cancer
peritoneal dialysis
radiation therapy
coronary artery bypass
coronary artery disease
early stage
sentinel lymph node
robot assisted
percutaneous coronary intervention
neoadjuvant chemotherapy
free survival